Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Pyroptosis is a form of programmed cell death characterized by inflammasome activation a...
Hepatocellular carcinoma remains one of the leading contributors to global cancer mortality, frequen...
: This study aimed to investigate whether small-cell lung cancer (SCLC) and non-small-cell lung canc...
Understanding the interaction between T Cell Receptors (TCRs) and peptide-bound Major Histocompatibi...
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) does not have distinct and highly sensitive bi...
INTRODUCTION: Prostate adenocarcinoma (PRAD) is an extremely widespread site of urological malignanc...
BACKGROUND: Microvascular invasion (MVI) is strongly associated with the prognosis of patients with ...
BACKGROUND: Epithelial ovarian cancer (EOC) is a deadly and heterogenous disease comprising five maj...
OBJECTIVE: Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The ris...
Sarcomas, a rare and complex group of cancers, require multidisciplinary care across multiple health...
OBJECTIVES: Lymphovascular invasion significantly impacts the prognosis of urothelial carcinoma of t...
PURPOSE: The study aimed to develop machine learning (ML) models for pretherapy prediction of absorb...
Artificial intelligence (AI) has emerged as a promising field in the era of personalized oncology d...
The investigation and diagnosis of hematologic malignancy using blood cell image analysis are major ...
PURPOSE: High-grade clear cell renal cell carcinoma (ccRCC) is linked to lower survival rates and mo...
: Despite great efforts from both clinical and pathological sides to address the extent of metastati...
OBJECTIVE: To develop an interpretable machine learning (ML) model using dynamic contrast-enhanced m...
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the predominant subtype of renal cancer, with...
PURPOSE: To develop and validate a predictor for early treatment response in hepatocellular carcinom...
Gold standard for immunohistochemical analyses is the manual assessment by two specialist pathologis...